Veraxa Biotech Holding AG (VRXA) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Veraxa Biotech Holding AG (VRXA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $299.8M, listed on NASDAQ, employing roughly 8 people, carrying a beta of 0.25 to the broader market. Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp. Led by Christoph Antz, public since 2026-06-09.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for VRXA as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →